Receptor tyrosine kinase (broad category; specific canonical names refer to each family or member, e.g., "Epidermal growth factor receptor" or "Insulin receptor") (RTK (for receptor tyrosine kinase); no single abbreviation for the general term "receptor kinase")

Receptor kinases are a large group of transmembrane cell-surface proteins that possess intrinsic enzymatic activity, catalyzing the phosphorylation of intracellular signaling proteins in response to extracellular ligand binding[1][4][10]. The best characterized subset is the receptor tyrosine kinases (RTKs), which play critical roles in cell growth, survival, differentiation, and metabolism, and are classified into at least 20 subfamilies including the epidermal growth factor receptor, insulin receptor, and vascular endothelial growth factor receptor families[1][2][6]. Ligand binding induces dimerization and trans-autophosphorylation of the receptor, initiating cascades such as MAPK/ERK and PI3K/Akt, crucial for many physiological and pathological processes[3][7][9][10]. Dysregulation of receptor kinases, especially RTKs, is implicated in cancer, metabolic diseases, and other disorders, making them major therapeutic targets. However, "receptor kinase" is an umbrella term and not a specific molecule; more precise identification (e.g., "Epidermal growth factor receptor" or "Insulin receptor") is necessary for structured biological or therapeutic data[1][4][10].

Other names

Protein kinase receptorreceptor tyrosine kinasereceptor serine/threonine kinaseenzyme-coupled receptor

Inhibition of kinase activity (by small molecules or antibodies); Prevention of ligand binding; Downregulation of receptor expression; Induction of receptor internalization/degradation